Possible effects of Osteocalcin and some biochemical parameters on kidney Function in Iraqi Diabetic Patients

Abstract

Chronic kidney disease (CKD) is a severe medical illness that is only worsening. Chronic renal failure (CKF) is the end stage of CKD, which is characterised by increasing loss of kidney function. We were to see if diabetes played a role in how osteocalcin (OCN) affected people who had renal failure. Between November 2021 and January 2022, 40 patients—20 with chronic renal disease with diabetes mellitus (T2DM) and 20 without—were transferred from a hospital to Emamain Al Khadhemain-education. The organisation is in charge of 28 healthy people. Minute. Each sample was separated into blood serum for ten minutes at 3000 revolutions per minute using the centrifuge. Age, BMI, and gender equality were among the information gathered from each participant. The Medical Research Unit of the University of Rivers' Faculty of Medicine conducted this investigation. In comparison to the control group (27.70 ± 3.46 mg/dL), CDK without T2DM and CDK with T2DM both displayed a substantial decrease in OCN (7.32 ± 1.52, P-value = <0.001; 12.35 ± 2.38, P-value = <0.001). Along with variations in calcium, phosphorus, urea, creatinine, vitamin D3, and other parameters, there were variations in insulin and fat.